| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.25B | +6.7% |
| Cost of Revenue | $902.8M | -2.6% |
| Gross Profit | $1.35B | +13.9% |
| R&D Expense | $120.3M | +31.8% |
| SG&A Expense | $1.07B | +4.2% |
| Operating Income | -$1.12B | -44.9% |
| Interest Expense | $34.8M | -39.0% |
| Pre-tax Income | -$1.16B | -40.9% |
| Income Tax | $22.3M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $36.4M | -24.5% |
| Accounts Receivable | $442.8M | +8.8% |
| Inventory | $584.4M | +6.8% |
| Current Assets | $1.21B | +5.3% |
| Total Assets | $3.83B | -18.7% |
| Current Liabilities | $598.5M | +13.1% |
| Long-term Debt | $1.30B | -2.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $217.3M | +91.4% |
| Capital Expenditures | $197.4M | +9.2% |
| Investing Cash Flow | -$179.4M | +81.2% |
| Financing Cash Flow | -$52.4M | -106.2% |
| Free Cash Flow | $19.9M | +129.6% |
| +396.3% |
| Net Income | -$1.18B | -43.5% |
| EPS (Basic) | -$20.75 | -39.0% |
| EPS (Diluted) | -$20.75 | -39.0% |
| Total Liabilities |
| $2.34B |
| +8.7% |
| Stockholders' Equity | $1.49B | -41.9% |